| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.008 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |